EADV President’s Symposium

EADV President’s Symposium – Controversies in dermatology: Hot topics

Discover the hot topics presented in this year’s President’s Symposium entitled “Controversies in dermatology”.

Current EADV President Prof. Luca Borradori, together with Prof. Erwin Tschachler (Past President) and Prof. Carle Paul (President Elect), will introduce and lead these stimulating lectures.

Eminent experts Dr. Robert Stern, Prof. Jean Jacques Grob and Prof. Tamar Nijsten will treat you with three provoking arguments.

Psoriasis and the place of biologics: The opinion leaders’ and industry‘s role
Robert Stern (Boston, United States)

Melanoma: From routine screening and sentinel lymph node to novel therapies. Is everything so clear cut?
Jean Jacques Grob (Marseille, France)

Inconvenient evidence in skin cancer care
Tamar Nijsten (Rotterdam, Netherlands)

 

Robert Stern (Boston, United States)

SternRobert S. Stern MD trained in economics at Harvard, medicine at Yale, and epidemiology at the National Institutes of Health and the Harvard Center for Community Health and Medical Care. He completed his dermatology training at the Harvard Mass General Hospital program. Since then, has been on the faculty of Harvard Medical School and now serves as the Carl J. Herzog Professor of Dermatology. From 2000 to 2017, he served as chair of the Department of Dermatology at Beth Israel Deaconess Medical Center at Harvard Medical School.

In addition to his clinical work and teaching, his investigational interests have been the application of economic and epidemiologic analysis to problems in dermatology and other aspects of healthcare. Within dermatology his research is principally focused on psoriasis, non-melanoma skin cancer and severe cutaneous adverse reactions to drugs. Outside of dermatology, his work has included studies of the costs of medical education, the impact of changes in reimbursement on institutional and provider behavior and on access to care for low income patients.

Among his most enjoyable academic activities has been his work with European colleagues particularly his work with the International SJS and TEN study led by Prof. Jean-Claude Roujeau, the Psonet study led by Prof. Luigi Naldi, and his work with his former fellow Prof. Tamar Nijsten.

 

Tamar Nijsten (Rotterdam, Netherlands)

NijstenTamar Nijsten did his medical and dermatology training in Antwerp, Belgium. During his PhD, he investigated the association between psoriasis therapies and skin cancer at Harvard Medical School (Boston, USA). In 2005, Tamar Nijsten joined the dermatology department at Erasmus MC, Rotterdam, the Netherlands, which he currently chairs. The focus of his research group is on the epidemiology and related aspects of different skin diseases, but with a special interest in skin cancer. Tamar Nijsten is dedicated to clinics and science, but likes to challenge existing paradigms in a scientific manner. He is author of over 250 international peer-reviewed papers, has given invited lectures at many (inter)national meetings, is section editor of the BJD and chairs the European Dermato-Epidemiology Network.

Beware of scams

Please beware of scam companies pretending to offer accommodation and registration to the EADV Congress (adding a percentage of commissions)!

Only trust information from our official websites:

·         eadv.org

·         eadvbudva2018.org

·         eadvparis2018.org

·         eadv.org/team (to contact the EADV Staff)

 

You have Successfully Subscribed!

Back to top